These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9481190)

  • 1. Monitoring diabetic control in developing countries: a review of glycated haemoglobin and fructosamine assays.
    Rahlenbeck SI
    Trop Doct; 1998 Jan; 28(1):9-15. PubMed ID: 9481190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glycosylated hemoglobin and glycosylated proteins for metabolic control of diabetes mellitus].
    Schnedl WJ; Leitner G; Lipp RW
    Wien Med Wochenschr; 1997; 147(15):359-61. PubMed ID: 9432808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs.
    Loste A; Marca MC
    Vet Res; 2001; 32(1):55-62. PubMed ID: 11254177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples.
    John WG; Scott KW; Hawcroft DM
    J Clin Pathol; 1988 Apr; 41(4):415-8. PubMed ID: 3366927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine determination as an index of glycaemic control: comparison between an automated and manual method, and the effect of serum storage.
    Ng WY; Thai AC; Lui KF; Koay ES
    Ann Acad Med Singap; 1989 Jul; 18(4):352-6. PubMed ID: 2802502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non enzymatic glycated proteins in the blood and cardiovascular disease.
    Misciagna G; De Michele G; Trevisan M
    Curr Pharm Des; 2007; 13(36):3688-95. PubMed ID: 18220807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can plasma fructosamine substitute for glycated haemoglobin (HbA1c) estimation in the assessment of diabetic control?
    Malik M; Gill GV; Pugh RN; Bakir A; Hossain M
    Trop Doct; 2000 Apr; 30(2):74-6. PubMed ID: 10842549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1C.
    Braatvedt GD; Drury PL; Cundy T
    N Z Med J; 1997 Dec; 110(1057):459-62. PubMed ID: 9451409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial measurement of serum fructosamine and glycosylated haemoglobin as indices of glycaemic control in diabetic pregnancy.
    Thai AC; Lui KF; Low EG; Ng WY; Kek LP
    Ann Acad Med Singap; 1991 Nov; 20(6):732-5. PubMed ID: 1803958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of glycated haemoglobin and glycated plasma proteins.
    Lester E
    Ann Clin Biochem; 1989 May; 26 ( Pt 3)():213-9. PubMed ID: 2669613
    [No Abstract]   [Full Text] [Related]  

  • 14. HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions.
    Ribeiro RT; Macedo MP; Raposo JF
    Curr Diabetes Rev; 2016; 12(1):14-9. PubMed ID: 26126638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in the assessment of glycaemic control in diabetes mellitus.
    Kilpatrick ES
    Diabet Med; 1997 Oct; 14(10):819-31. PubMed ID: 9371473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs.
    Davison LJ; Podd SL; Ristic JM; Herrtage ME; Parnham A; Catchpole B
    J Small Anim Pract; 2002 Dec; 43(12):526-32. PubMed ID: 12489740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical validity of a self-test fructosamine in outpatient diabetic management.
    Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
    Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of fructosamine for monitoring outpatients with diabetes.
    Austin GE; Wheaton R; Nanes MS; Rubin J; Mullins RE
    Am J Med Sci; 1999 Nov; 318(5):316-23. PubMed ID: 10555094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of fructosamine determination in diabetic patients and its relation to metabolic control.
    Daubresse JC; Laurent E; Ligny C; Bailly A; Lemy C; Duchateau A; Meunier JC
    Diabete Metab; 1987 Jun; 13(3):217-21. PubMed ID: 3609423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.